Abstract: A method for circumscribing an insulating barrier region around a singular conductive microneedle structure or plurality of conductive microneedle structures adhered to a fixed substrate for the purpose of spatially defining a conduit for the routing of an electrical signal from the surface of said microneedle or microneedles to the posterior surface of the substrate is disclosed herein. A microneedle-based electrochemical biosensors structure comprises a substrate, a microneedle biosensor, a primary electrically conductive element, a secondary electrically conductive element and an electrically insulative annular barrier.
Type:
Grant
Filed:
March 6, 2018
Date of Patent:
October 8, 2024
Assignee:
Biolinq Incorporated
Inventors:
Joshua Windmiller, James Patrick McCanna, Jared Rylan Tangney
Abstract: Aspects of the current subject matter are directed to a sensor assembly of an analyte monitoring device including one or more microneedle arrays. Aspects are directed to components and architecture of a sensor assembly to implement power and processing aspects of a microneedle array-based continuous analyte monitoring device for the detection and measuring of an analyte. A source of a power-on event is determined, and the analyte monitoring device is transitioned to a mode that corresponds to the determined source. When a power-on event is determined to be a valid power-on event, the analyte monitoring device is transition to a mode that corresponds to a type of the valid power-on event.
Type:
Grant
Filed:
July 5, 2023
Date of Patent:
August 27, 2024
Assignee:
Biolinq Incorporated
Inventors:
Daniel Alonso-Soski, Anderson Micu, Yan Li, Christopher Griffith, Jennifer Ruth Walters Fuchs
Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.
Type:
Grant
Filed:
December 21, 2022
Date of Patent:
June 18, 2024
Assignee:
Biolinq Incorporated
Inventors:
Alan Campbell, Sirilak Sattayasamitsathit, Jared Rylan Tangney, Thomas Arnold Peyser, Joshua Ray Windmiller
Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
Type:
Grant
Filed:
April 25, 2023
Date of Patent:
May 21, 2024
Assignee:
Biolinq Incorporated
Inventors:
George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
Abstract: A skin-adorned physiological or biochemical sensing device is disclosed herein. The device preferably comprises a first substrate and a second substrate. The first substrate comprises an array of solid microneedles designed to penetrate a biological interface to access a physiological fluid or tissue. Each microneedle is capable of electrical interface with the physiological fluid or tissue. The second substrate comprises integrated circuitry designed to transduce at least one signal produced by an electrophysiological or electrochemical reaction. A sensing device is formed that is capable of interpreting the signal arising from the electrophysiological or electrochemical reaction to ascertain the level of some physiological or biochemical entity.
Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
Type:
Grant
Filed:
April 25, 2023
Date of Patent:
February 20, 2024
Assignee:
Biolinq Incorporated
Inventors:
George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.
Type:
Grant
Filed:
October 21, 2022
Date of Patent:
January 16, 2024
Assignee:
Biolinq Incorporated
Inventors:
Jared Rylan Tangney, Joshua Ray Windmiller, Richard Chien Yang
Abstract: Fault detection and diagnostics for a microneedle array based continuous analyte monitoring device are provided. The electrochemical sensors, including the electrodes of the analyte monitoring device configured for measuring one or more target analytes, may experience various faults during use of the analyte monitoring device. By modeling the sensors as an electrical network, measurements of the electrical network may be correlated with operational parameters of the sensor. The voltage at the counter electrode provides an indication of the resistance or impedance between the working electrode and the counter electrode and is used to identify the occurrence of faults occurring at the continuous analyte monitoring device.
Type:
Grant
Filed:
May 6, 2022
Date of Patent:
January 2, 2024
Assignee:
Biolinq Incorporated
Inventors:
Joshua Ray Windmiller, Alan Steven Campbell, Jared Rylan Tangney
Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
Type:
Grant
Filed:
September 27, 2022
Date of Patent:
June 13, 2023
Assignee:
Biolinq Incorporated
Inventors:
George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.
Type:
Grant
Filed:
September 27, 2022
Date of Patent:
May 23, 2023
Assignee:
Biolinq Incorporated
Inventors:
George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner, Paul Daniel Faucher